CarthroniX has entered into a collaboration with SMC Labs, Japan to explore the therapeutic potential of novel systemic gp130 modulators in animal models of chronic inflammatory and fibrotic disorders. SMC Labs is one of the leading CRO’s in this area specializing in pre-clinical models for drug development. SMC Labs is a pre-clinical CRO development through focused